Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
复制标题
临床和实验性主动脉瘤疾病中缺氧诱导因子1。
DOI:
10.1016/j.jvs.2017.09.030
复制
发表时间:
2018-11
影响因子:
4.3
通讯作者:
Dalman RL
中科院分区:
文献类型:
--
作者:
Wang W;Xu B;Xuan H;Ge Y;Wang Y;Wang L;Huang J;Fu W;Michie SA;Dalman RL
Mural angiogenesis and macrophage accumulation are two pathological hallmarks of abdominal aortic aneurysm (AAA) disease. The heterodimeric transcription factor, hypoxia inducible factor (HIF)-1, is an essential regulator of angiogenesis and macrophage fucntion. In this study we investigated HIF-1 expression and activity in clinical and experimental AAA disease. Human aortic samples were obtained from 24 AAA patients and six organ donors during open abdominal surgery. Experimental AAAs were created in 10 weeks old male C57BL/6J mice by transient intra-aortic infusion of porcine pancreatic elastase. Expression of HIF-1α and its target gene mRNA levels were assessed in aneurysmal and control aortae. The HIF-1α inhibitors 2-methoxyestradiol or digoxin, or the prolyl-hydroxylase domain-containing protein inhibitors cobalt chloride and JNJ-42041935, or vehicle-alone as control, were administered daily to mice at varying timing points beginning before or after porcine pancreatic elastase infusion. Influences on experimental AAA formation and progression were assessed via serial transabdominal ultrasonographic assessment of aortic diameter and histopathologic analysis at sacrifice. mRNA levels for HIF-1α, vascular endothelial growth factor-A, glucose transporter-1 and matrix metalloproteinase 2 were significantly increased in both human and experimental aneurysm tissue. Tissue immunostaining detected more HIF-1α protein in both human and experimental aneurysmal, as compared to respective control aortae. Treatment with either HIF-1α inhibitor, beginning either before or after porcine pancreatic elastase infusion, prevented enlargement of experimental aneurysms. Both HIF-1α inhibition regimens attenuated medial elastin degradation, smooth muscle cell depletion, mural angiogenesis, and the accumulation of macrophages, T cells and B cells. While mRNA levels for prolyl-hydroxylase domain-containing protein (PHD) 1 and PHD 2 were elevated in experimental aneurysmal aortae, pharmacological inhibition of PHDs had limited effect on experimental aneurysm progression. Expression of HIF-1α and its target genes are increased in human and experimental AAAs. Treatment with HIF-1α inhibitors limits experimental AAA progression, with histologic evidence of attenuated mural leukocyte infiltration and angiogenesis. These findings underscore the potential significance of HIF-1α in aneurysm pathogenesis and as a target for pharmacologic suppression of AAA disease.
登录
查看更多内容
影响因子:
4.6
作者:
Daijo H;Hoshino Y;Kai S;Suzuki K;Nishi K;Matsuo Y;Harada H;Hirota K
通讯作者:
Hirota K
影响因子:
50.3
作者:
Mabjeesh, NJ;Escuin, D;Giannakakou, P
通讯作者:
Giannakakou, P
影响因子:
64.5
作者:
Dang EV;Barbi J;Yang HY;Jinasena D;Yu H;Zheng Y;Bordman Z;Fu J;Kim Y;Yen HR;Luo W;Zeller K;Shimoda L;Topalian SL;Semenza GL;Dang CV;Pardoll DM;Pan F
通讯作者:
Pan F
影响因子:
4.3
作者:
Mayranpaa, Mikko I.;Trosien, Julia A.;Hedin, Ulf
通讯作者:
Hedin, Ulf
影响因子:
4.3
作者:
Kent, K. Craig;Zwolak, Robert M.;Greco, Giampaolo
通讯作者:
Greco, Giampaolo